Defining Immune Tolerance in ANCA-associated Vasculitis (AAV)
- Conditions
- ANCA-Associated Vasculitis
- Interventions
- Procedure: Venipuncture for blood sample collection
- First Posted Date
- 2013-09-04
- Last Posted Date
- 2016-05-20
- Target Recruit Count
- 33
- Registration Number
- NCT01934504
- Locations
- π¬π§
University College London, Centre for Nephrology, London, England, United Kingdom
π¬π§Addenbrooke's Hospital, Cambridge, England, United Kingdom
π¬π§Hammersmith Hospital, London, England, United Kingdom
Evaluating the Safety and Efficacy of Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
- First Posted Date
- 2013-09-02
- Last Posted Date
- 2021-11-01
- Target Recruit Count
- 59
- Registration Number
- NCT01933594
- Locations
- πΊπΈ
Penn Therapeutics, CRS, Philadelphia, Pennsylvania, United States
πΊπΈUniversity of Pittsburgh CRS, Pittsburgh, Pennsylvania, United States
πΊπΈUniversity of Washington AIDS CRS, Seattle, Washington, United States
Evaluating the Safety and Immune Response to a Dengue Virus Vaccine in Healthy Adults
- Conditions
- Dengue
- Interventions
- Biological: rDEN2Ξ30-7169 vaccineBiological: Placebo
- First Posted Date
- 2013-08-29
- Last Posted Date
- 2015-12-15
- Target Recruit Count
- 14
- Registration Number
- NCT01931176
- Locations
- πΊπΈ
John Hopkins Bloomberg School of Public Health - Center for Immunization Research (CIR), Baltimore, Maryland, United States
Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South Africa
- Conditions
- HIV Infections
- Interventions
- Biological: NYVAC-HIV-PT1 vaccineBiological: DNA-HIV-PT123 vaccineBiological: NYVAC-HIV-PT4 vaccineBiological: AIDSVAX B/E vaccineBiological: Placebo for DNA/NYVAC/AIDSVAX
Leprosy Skin Test Antigens Phase 1
- Conditions
- Leprosy
- Interventions
- Biological: MLCwABiological: MLSA-LAMOther: Mock Antigen
- First Posted Date
- 2013-08-12
- Last Posted Date
- 2014-07-25
- Target Recruit Count
- 10
- Registration Number
- NCT01920750
Study of the Complications Associated With Certain Stem Cell Transplants
- Conditions
- Post-Transplant InfectionsPost-Transplant Renal InsufficiencyPost-Transplant Pulmonary Complications
- First Posted Date
- 2013-08-08
- Last Posted Date
- 2024-03-22
- Target Recruit Count
- 100
- Registration Number
- NCT01919099
- Locations
- πΊπΈ
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Study of Antibiotic-induced Vaginal Yeast Infections in Healthy Women
- Conditions
- Vaginal CandidiasisMicrobiomeAntibiotic-Induced VVC
- First Posted Date
- 2013-08-02
- Last Posted Date
- 2019-09-12
- Target Recruit Count
- 13
- Registration Number
- NCT01915251
- Locations
- πΊπΈ
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection
- First Posted Date
- 2013-08-02
- Last Posted Date
- 2025-06-05
- Target Recruit Count
- 69
- Registration Number
- NCT01915212
- Locations
- πΊπΈ
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03)
- Conditions
- Influenza A Virus, H5N1 Subtype
- Interventions
- Biological: H5N1 vaccine plus AS03 adjuvantBiological: H5N1 vaccine without adjuvant
- First Posted Date
- 2013-07-29
- Last Posted Date
- 2019-02-12
- Target Recruit Count
- 50
- Registration Number
- NCT01910519
- Locations
- πΊπΈ
The Hope Clinic - Emory Vaccine Center, Decatur, Georgia, United States
Evaluating the Safety and Immune Response of DNA/MVA Vaccines in HIV-1-Infected Young Adults Taking Anti-HIV Medications
- Conditions
- HIV Infections
- Interventions
- Biological: Placebo for DNA GEO-D03Biological: GEO-D03 DNA VaccineBiological: MVA/HIV62B VaccineBiological: Placebo for MVA/HIV62B Vaccine